NO2020014I1 - ciclesonide - Google Patents

ciclesonide

Info

Publication number
NO2020014I1
NO2020014I1 NO2020014C NO2020014C NO2020014I1 NO 2020014 I1 NO2020014 I1 NO 2020014I1 NO 2020014 C NO2020014 C NO 2020014C NO 2020014 C NO2020014 C NO 2020014C NO 2020014 I1 NO2020014 I1 NO 2020014I1
Authority
NO
Norway
Prior art keywords
ciclesonide
Prior art date
Application number
NO2020014C
Other languages
English (en)
Norwegian (no)
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2020014(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of NO2020014I1 publication Critical patent/NO2020014I1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO2020014C 2012-12-21 2020-06-12 ciclesonide NO2020014I1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21

Publications (1)

Publication Number Publication Date
NO2020014I1 true NO2020014I1 (no) 2020-06-12

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2020014C NO2020014I1 (no) 2012-12-21 2020-06-12 ciclesonide

Country Status (24)

Country Link
US (4) US20140179651A1 (enExample)
EP (1) EP2934479B1 (enExample)
AR (1) AR094241A1 (enExample)
AU (2) AU2013360691B2 (enExample)
BR (2) BR122016029247A2 (enExample)
CA (1) CA2888428C (enExample)
CY (2) CY1121115T1 (enExample)
DK (1) DK2934479T3 (enExample)
ES (1) ES2693779T3 (enExample)
FR (1) FR20C1026I1 (enExample)
HR (1) HRP20181980T1 (enExample)
HU (1) HUS2000020I1 (enExample)
IN (1) IN2015DN02894A (enExample)
LT (2) LT2934479T (enExample)
MA (1) MA38169B2 (enExample)
MX (1) MX368306B (enExample)
NO (1) NO2020014I1 (enExample)
NZ (1) NZ706573A (enExample)
PL (1) PL2934479T3 (enExample)
PT (1) PT2934479T (enExample)
RS (1) RS57740B1 (enExample)
SI (1) SI2934479T1 (enExample)
WO (1) WO2014096115A1 (enExample)
ZA (1) ZA201502288B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
HRP20181980T1 (hr) 2012-12-21 2019-01-25 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za liječenje dišnih puteva kod konja
ES2706757T3 (es) 2012-12-21 2019-04-01 Boehringer Ingelheim Vetmedica Gmbh Formulación farmacéutica que comprende ciclesonida
WO2015193213A1 (en) 2014-06-18 2015-12-23 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
US11191746B2 (en) * 2016-10-14 2021-12-07 Jeju National University Industry-Academic Cooperation Foundation Composition for inhibiting a growth of cancer stem cells comprising ciclesonide
US20230033224A1 (en) * 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
EP4188327B1 (en) 2020-07-31 2025-05-28 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
EP1763344A1 (en) 2004-06-29 2007-03-21 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
BRPI1011813B1 (pt) 2009-06-25 2020-08-04 Boehringer Ingelheim Vetmedica Gmbh Inalador
US7829748B1 (en) * 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
HRP20181980T1 (hr) 2012-12-21 2019-01-25 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za liječenje dišnih puteva kod konja
ES2706757T3 (es) 2012-12-21 2019-04-01 Boehringer Ingelheim Vetmedica Gmbh Formulación farmacéutica que comprende ciclesonida
AR097394A1 (es) 2013-08-20 2016-03-09 Boehringer Ingelheim Vetmedica Gmbh Inhalador
CA2913811C (en) 2013-08-20 2022-06-07 Boehringer Ingelheim Vetmedica Gmbh Inhaler
WO2015193213A1 (en) 2014-06-18 2015-12-23 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

Also Published As

Publication number Publication date
MX368306B (es) 2019-09-27
BR112015010842A8 (pt) 2019-10-01
SI2934479T1 (sl) 2019-01-31
IN2015DN02894A (enExample) 2015-09-11
MX2015007947A (es) 2015-10-08
AU2018201642B2 (en) 2019-01-31
BR112015010842B1 (pt) 2021-03-30
FR20C1026I1 (fr) 2020-10-02
CY2020015I2 (el) 2021-03-12
WO2014096115A1 (en) 2014-06-26
CY2020015I1 (el) 2020-11-25
LTPA2020511I1 (lt) 2020-07-27
EP2934479B1 (en) 2018-09-19
ZA201502288B (en) 2019-09-25
PL2934479T3 (pl) 2019-02-28
US20180153907A1 (en) 2018-06-07
HUS2000020I1 (hu) 2020-07-28
CA2888428A1 (en) 2014-06-26
LT2934479T (lt) 2018-12-27
US20140179651A1 (en) 2014-06-26
AU2013360691B2 (en) 2018-03-08
CA2888428C (en) 2021-07-13
BR112015010842A2 (pt) 2017-07-11
RS57740B1 (sr) 2018-12-31
ES2693779T3 (es) 2018-12-13
DK2934479T3 (en) 2018-11-05
US10258634B2 (en) 2019-04-16
AU2018201642A1 (en) 2018-03-29
MA38169B2 (fr) 2021-08-31
AR094241A1 (es) 2015-07-22
BR122016029247A2 (pt) 2019-08-20
PT2934479T (pt) 2018-12-20
CY1121115T1 (el) 2019-12-11
US10441597B2 (en) 2019-10-15
MA38169A1 (fr) 2017-01-31
US20170079988A1 (en) 2017-03-23
US9918995B2 (en) 2018-03-20
NZ706573A (en) 2019-11-29
AU2013360691A1 (en) 2015-04-16
EP2934479A1 (en) 2015-10-28
HRP20181980T1 (hr) 2019-01-25
US20150313918A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
EP2880683A4 (en) BVA INTERPOSER
DK2825087T3 (da) Otoscanner
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
EP2847405A4 (en) DOOR CLOSURE SYSTEM
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en) Charging cable
EP2805877A4 (en) UNDER HOOD
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
EP2941099A4 (en) SWITCHING DEVICE
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
EP2869113A4 (en) GAHRZEUGANZEIGEVORRICHTUNG
EP2862179A4 (en) WIRBELSTROMPRÜFSONDE
DK3132666T3 (da) Slåmaskine
DE112012006214T8 (de) Wulstringwickler
DK2831122T3 (da) Anthocyanidin-kompleks
DK2885638T3 (da) Molekylenet
EP2873363A4 (en) DIOPSIMETER